Abstract
Objective Electroconvulsive therapy (ECT) is one of the most studied and validated available treatments for severe or treatment-resistant depression. However, little is known about the neural mechanisms underlying the ECT treatment. This systematic review aims to critically review all structural magnetic resonance imaging studies investigating longitudinal cortical thickness (CT) changes after ECT in patients with unipolar or bipolar depression.
Methods We performed a search on PubMed, Medline, and Embase to identify all available studies published before April 20, 2023. A total of 10 studies were included.
Results The investigations showed widespread increases in CT after ECT in depressed patients, involving mainly the temporal, insular, and frontal regions. In five studies, CT increases in a non-overlapping set of brain areas correlated with the clinical efficacy of ECT. The small sample size, heterogeneity in terms of populations, medications, comorbidities, and ECT protocols, and the lack of a control group in some investigations limit the generalizability of the results.
Conclusions Our findings support the idea that ECT can increase CT in patients with unipolar and bipolar depression. It remains unclear whether these changes are related to the clinical response. Future larger studies with longer follow-up are warranted to thoroughly address the potential role of CT as a biomarker of clinical response after ECT.
Summations
This review summarizes how ECT affects CT in patients with unipolar or bipolar depression.
The areas that were predominantly affected by ECT were temporo-insular and frontal regions. An association between the antidepressant effect of ECT and CT changes was reported by half of the included studies.
Identifying the possible cortical changes associated with the clinical efficacy of ECT opens new targets to ameliorate ECT protocols.
Considerations The review is based on studies with small numbers of patients and considerable heterogeneity in terms of patients’ characteristics and ECT protocols. Most studies cited did not have a randomized design, thus reducing the strength of evidence supporting a causal link between ECT and CT changes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GC was supported by a grant from Cassa di Risparmio di Padova e Rovigo (CARIPARO)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
State that source data were openly available before the initiation of the study and descrive how they can be located by provinding links to all download pages of the original data sources
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Corrected some names of the authors
Data Availability
All data produced in the present work are contained in the manuscript
